Using Real‐World Data to Extrapolate Evidence From Randomized Controlled Trials-Reference-Cited by-同舟云学术

Using Real‐World Data to Extrapolate Evidence From Randomized Controlled Trials

Published:2018-09-24 Issue:5 Volume:105 Page:1156-1163
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wang Shirley V.¹,Schneeweiss Sebastian¹,Gagne Joshua J.¹,Evers Thomas²,Gerlinger Christoph³⁴,Desai Rishi¹,Najafzadeh Mehdi¹

Affiliation:

1. Division of Pharmacoepidemiology and PharmacoeconomicsDepartment of MedicineBrigham and Women's HospitalHarvard Medical School Boston Massachusetts USA

2. Market AccessBayer AG Wuppertal Germany

3. Statistics and Data InsightsBayer AG Berlin Germany

4. Obstetrics and GynecologySaarland UniversityHomburg/SaarGermany

Funder

Bayer

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1210

Reference28 articles.

1. Disparate Inclusion of Older Adults in Clinical Trials: Priorities and Opportunities for Policy and Practice Change

2. Including elderly people in clinical trials

3. Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease

4. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

5. Exclusion of Women of Childbearing Potential in Clinical Trials of Type 2 Diabetes Medications: A Review of Protocol-Based Barriers to Enrollment

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With Major Lower Extremity Amputations in Diabetic Foot Infections at a County Hospital in Guatemala;Journal of Surgical Research;2024-10

2. From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy;Clinical Pharmacology & Therapeutics;2024-04-24

3. Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications;Bone Reports;2024-03

4. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention;Handbook of Clinical Neurology;2024

5. Cost‐effectiveness of zinc interventions in China: A cohort‐based Markov model;Agribusiness;2023-10-11